The Claim
In adults with nonalcoholic fatty liver disease (NAFLD), a 12-week intervention with GLS (Coptidis Rhizoma-Evodiae Fructus 2:1) at a dose of 8.12 g/day, combined with lifestyle modification, probably leads to greater reductions in hepatic fat accumulation—measured by controlled attenuation parameter (CAP)—compared to polyene phosphatidylcholine (PPC), with a mean CAP reduction of 35.6 dB/m versus 20.8 dB/m, indicating a more substantial improvement in liver fat content.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For people with fatty liver disease, taking a specific herbal mix called GLS for 12 weeks—along with healthy lifestyle changes—might reduce liver fat more than another supplement called PPC.
See the scientific wording
In adults with nonalcoholic fatty liver disease (NAFLD), a 12-week intervention with GLS (Coptidis Rhizoma-Evodiae Fructus 2:1) at 8.12 g/day, combined with lifestyle modification, probably leads to greater reductions in hepatic fat accumulation—measured by controlled attenuation parameter (CAP)—compared to polyene phosphatidylcholine (PPC), with a mean CAP reduction of 35.6 dB/m versus 20.8 dB/m, indicating a more substantial improvement in liver fat content.
What the research says
1 studyThe study tested the same herb and dose in the same group of patients and found it worked better than the comparison treatment at reducing liver fat, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.